The autologous stem cell and non-stem cell–based therapies market is experiencing rapid evolution as healthcare systems prioritize regenerative and patient-specific treatments. Unlike conventional drug therapies, autologous treatments are designed using a patient’s own cells, making them inherently compatible and reducing safety concerns related to immune rejection. Autologous stem...